Palisade Bio, Inc.
PALI
$2.14
-$0.01-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.57M | -9.60M | -8.90M | -2.87M | -2.78M |
| Total Depreciation and Amortization | -- | -- | 0.00 | 1.00K | 1.00K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 75.00K |
| Total Other Non-Cash Items | 4.77M | 4.30M | 3.64M | 383.00K | 92.00K |
| Change in Net Operating Assets | -1.80M | 1.41M | 2.11M | -1.07M | 799.00K |
| Cash from Operations | -7.60M | -3.89M | -3.14M | -3.55M | -1.82M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -71.00K | -140.00K | -100.00K | 0.00 |
| Issuance of Common Stock | 175.00K | 3.25M | 131.96M | 3.91M | 4.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -28.00K | -46.00K | -490.00K | -445.00K | 0.00 |
| Cash from Financing | 147.00K | 3.13M | 131.33M | 3.36M | 4.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.46M | -757.00K | 128.19M | -190.00K | -1.81M |